Total | Group 1 | Group 2 | |
---|---|---|---|
(n = 212) | (n = 104) | (n = 108) | |
Antiviral treatment, n (%) | 196 (92.5) | 95 (91.3) | 101 (93.5) |
data not available, n (%) | 16 (7.5) | 9 (8.7) | 7 (6.5) |
Preoperative complete VR, n (%) | 46 (21.7) | 46 (44.2) | - |
Post-operative complete VR, n (%) | 128 (60.4) | 80 (76.9) | 48 (44.4) |
Post-operative partial VR, n (%) | 53 (25.0) | 1 (1.0) | 52 (48.1) |
Post-operative virological breakthrough, n (%) | 14 (6.6) | 11 (10.6) | 3 (2.8) |